2024年　業績集

原著

1. Postoperative Geriatric Nutritional Risk Index as a Determinant of Tolerance to S-1 Adjuvant Chemotherapy After Curative Surgery for Pancreatic Ductal Adenocarcinoma:A Cohort Study with External Validation. Funamizu N, et al. Cancers (Basel). 2025 Apr 26;17(9):1448. doi: 10.3390/cancers17091448.
2. Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study.Funamizu N, et al. Sci Rep. 2025 May 16;15(1):17000. doi: 10.1038/s41598-025-02365-5.
3. Clinical significance of postoperative cardiothoracic ratio for postoperative pleural effusion following hepatectomy. Sakamoto A, et al. BMC Surg. 2025 Nov 4;25(1):523. doi:10.1186/s12893-025-03109-y.
4. Impact of reconstructed portal vein morphology on postoperative nutritional status in pancreatoduodenectomy:a computational fluid dynamics study. Sakamoto K, Iwamoto Y, Ogawa K, Oguzhan Sal, Tamura K, et al. Surg Today. 2025 Mar;55(3):445-451. doi: 10.1007/s00595-024-02903-0. Epub 2024 Jul 30.
5. Semaphorin 3F inhibits breast cancer metastasis by regulating the Akt-mTOR and TGFβ signaling pathways via neuropilin-2. Nakayama H, Murakami A, et al. Sci Rep.2025 Mar 3;15(1):7394.doi:10.1038/s41598-025-91559-y.
6. Diagnostic accuracy of a machine learning model using radiomics features from breast synthetic MRI. Matsuda T, Matsuda M, Haque H, Fuchibe S, Matsumoto M, Shiraishi Y, Nobe Y, Kuwabara K, Toshimori W, Okada K, Kawaguchi N, Kurata M, Kamei Y, et al. BMC Med Imaging.2025 Sep 29;25(1):399.doi:10.1186/s12880-025-01930-8.
7. Usefulness of four-dimensional noise reduction filtering using a similarity algorithm in low-dose dynamic computed tomography for the evaluation of breast cancer:a preliminary study. Uraoka D, Matsuda M, Tanabe Y, Kawaguchi N, Nishiyama C, Okada A, Uda K, Suekuni H, Nishiyama H, Kamei Y, et al. Japanese Journal of Radiology.2025 May;43(5):787-799.doi:10.1007/s11604-024-01730-0.Epub 2025 Jan 24.
8. Upright Light-Sheet Microscopy with Two-Photon Excitation for Imaging Large Samples. Saitou T, Takanezawa S, Kawakami R, Kobayashi-Taguchi K, et al. Bioimages.2025 Volume 33:1-13 doi:10.11169/bioimages.33.1.

症例報告

1. Long-term survival in a patient with postoperative pulmonary oligometastasis of pancreatic cancer treated with surgical resection and chemotherapy: A case report. Funamizu N, Funamizu N, et al. Medicine (Baltimore).2025 Aug 1;104(31):e43647.doi:10.1097/MD.
2. Tirzepatide-induced weight loss and obstructive sleep apnea improvement in an adult with type 2 diabetes : A case report. Funamizu N, Funamizu N, et al. Medicine (Baltimore).2025 Oct 24;104(43):e45445.doi:10.1097/MD.0000000000045445.
3. Robot assisted anatomical liver resection is safe for patient with hepatocellular carcinoma underlying Fontan-associated liver disease. Oguzhan Sal, Sakamoto K, Tamura K, et al. Hepatobiliary Pancreat Dis Int. 2025 Feb;24(1):111-113. doi: 10.1016/j.hbpd.2024.07.007. Epub 2024 Jul 19.
4. IgG4関連硬化性乳腺炎を併存した乳癌のⅠ例. 青野真由子、野田令菜、他. 日臨外会誌 86 (9),1138-1145,2025

総説

1. Nutritional Status and Chemotherapy Completion in Resectable Pancreatic Cancer: A Narrative Review. Funamizu N, et al. Curr Oncol. 2025 Sep 17;32(9):519. doi: 10.3390/curroncol32090519.

著書

1. 手術記録の描き方・活かし方　第2版　金芳堂. 楳田祐三
2. 【カラダを知ればケアがみえる　解剖＆病態生理の冒険へ！消化器臓器の歩きかた】膵臓の冒険. 船水尚武、他．消化器ナーシング (2434-4575) 30巻3号　Page241-253 (2025.03)
3. mucocele-like lesionやADHと診断された場合，どのような対応をすべきですか？. ここが知りたい！乳癌診療現場のギモン 2025;17. 村上朱里
4. 術後の閉創・創部管理. エキスパートが伝える スタンダード乳癌手術 176-178. 村上朱里

国際学会

1. Specific issues. 村上朱里. ベスト オブ SABCS（サンアントニオ乳癌シンポジウム）2024イン京都　2.1-2　オンライン
2. Randomized phase 2 study of paclitaxel plus bevacizumab induction followed by atezolizumab plus nab-paclitaxel in patients with PD-L1-positive metastatic triple-negative breast cancer with biomarker analysis (JBCRG-M10/INDUCE). Ozaki Y, Koyama S, Morita S, Sugibayashi S, Miyashita M, Tokuda E, Shimoi T, Fukuoka M, Masuda H, Takano Y, Shibata N, Yoshinami T, Murakami A, at al.　ESMO Congress 2025 2025.10.17-21 ベルリン
3. MIRAY1：Fostering Next generation Professionals and Networks in Breast Cancer in Japan. Kitazawa M, Tane K, Iwasa T, Nagayama A, Takahashi Y, Ozaki A, Inoue Y, Kimura Y, Tachibana K, Hara Y, Murakami A, et al. TIBCS 2025 2025.10.25-26 台湾
4. Relationship between the Incidence of Osteonecrosis of the Jaw due to Bone-Modifying Drugs Administered for Bone Metastases of Breast Cancer, Risk Factors, and Overall Survival. Murakami A, et al. San Antonio Breast Cancer Symposium 2025.12.9-12 Texas
5. Ultrasound-guided biopsy-based tils assessment at tumor margins as a predictive biomarker of neoadjuvant treatment response in early her2-positive and triple-negative breast cancer:a multicenter study. Kimura Y, Yamaguchi R, Fukui K, Kanou A, Noma M, Akashi-Tanaka S, Arihiro K, Iwamoto N, Ohta Y, Okuno T, Kashiwagi S, Kamei Y, et al. San Antonio Breast Cancer Symposium 2025.12.9-12 Texas.

学会発表

1. 学会発表（全国学会・研究会）
2. 学会発表（地方会）

詳細はPDFにてご確認ください。